Future Care For Medical Industries
EEGX:FCMD7.30
EGP
-0.03
(-0.41%)
ISIN
EGS3I0S1C019
Return %
Stock
S&P 500
1Y
200.92
14.20
3Y
940.57
81.12
5Y
776.50
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Amr Mohammed Mohammed Abdel Hakim
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Giza Egypt
- IPO Date
- Dec 31, 2012
- Website
- icmiegypt.com
- Similar Companies
- Business
- Future Care for Medical Industries S.A.E. (EGX: FCMD), formerly known as the International Company for Medical Industries (ICMI), is an Egypt-based healthcare manufacturing and trading company that specializes in the development, production, packaging, and distribution of sterile medical supplies, surgical consumables, personal care solutions, and nutritional products. Founded in 1994 and headquartered in Giza, Egypt, with production and logistics facilities located in the Abu Rawash Industrial Zone and 6th of October City, the company operates across the medical equipment, pharmaceuticals, and healthcare consumables sectors, serving public and private hospitals, clinical laboratories, surgical centers, and commercial retail pharmacies across Egypt and the broader Middle East and Africa (MEA) region. The company operates through several primary product and service segments: surgical wound closure products, including non-absorbable surgical sutures, synthetic absorbable sutures, polypropylene sutures, and surgical wire across diverse gauge specifications; precision medical hardware and injection components, including sterile needle tips, hypodermic needles, and specialized medical disposables, where the company acts as the exclusive regional distributor for the Mizawa brand; personal care and hygiene goods, including sterile medical wipes, antibacterial wet wipes, dry wipes, and household disinfectant wipes; specialized dermatological cosmetics, including topical skincare formulations and antiseptic treatments; and over-the-counter wellness products, including dietary supplements, vitamin compounds, and therapeutic nutritional aids. In addition to primary manufacturing, the company offers contract sterilization, cleanroom packaging, regulatory clearance distribution, and import-export representation for global medical brands. In recent corporate developments, the company executed a comprehensive corporate rebranding in April 2026, officially transitioning its trade name from International Company for Medical Industries to Future Care for Medical Industries and updating its Egyptian Exchange ticker code to FCMD. In June 2026, the company completed a substantial capital increase via a rights issue that raised its issued shares to 115,171,796 and expanded its equity base past EGP 115 million to finance facility refurbishments and upgrade production infrastructure to global sterile manufacturing standards. Following this financial expansion and fulfillment of listing criteria, the company successfully transferred in August 2026 from the Nile Exchange (Nilex) for small and medium enterprises to the EGX Main Market. Concurrently, the company has advanced strategic diversification initiatives, including expanding into advanced hygiene products and pursuing strategic acquisition opportunities targeting domestic medical apparel and hospital textiles manufacturers.